|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss - including non-controlling interest | |||||
| Net Loss | |||||
| Share-Based Payment Arrangement, Noncash Expense | |||||
| Unrealized loss on marketable securities | |||||
| Amortization of debt discount | |||||
| Depreciation expense | |||||
| Accounts receivable | |||||
| Gain on settlement of accounts payable | |||||
| Loss (gain) on remeasurement of derivative | |||||
| Loss (gain) on derivative | |||||
| Changes in operating assets and liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable and accrued expenses | |||||
| Net cash used in operating activities | |||||
| Short -term advances -related party | |||||
| Proceeds from short-term advances - related parties | |||||
| Proceeds from note – related parties | |||||
| Net cash provided by financing activities | |||||
| Net change in cash | |||||
| Cash and cash equivalents - beginning of period | |||||
| Cash and cash equivalents - end of period | |||||
| Supplemental disclosure of non-cash activities | |||||
| Reversal of accrued expense payable | |||||
| Total non-cash operating activities | |||||
| Conversion of debt to equity (principal + accrued interest) | |||||
Loading...